Argenx Se ARGX
NASDAQ ARGX
$818.95 -27.32 (-3.23%)
As of: Oct 16, 2026 · 3:59 PM EDT

Argenx Se (ARGX) Interest & Investment Income (2016 - 2026)

Updated

Argenx Se's Interest & Investment Income came in at $48 million for Q2 2026, up 25.0% from $38.4 million a year earlier and up 9.1% from the prior quarter.

Analysis

Argenx Se (ARGX) Interest & Investment Income (2016 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Argenx Se reported Interest & Investment Income of $179.57 million, up 15.8% year-over-year; for FY2025, it was $163.09 million, up 3.5% from FY2024.

  • Interest & Investment Income has increased in each of the last four years, with a five-year compound annual growth rate of 90.7% (FY2020 to FY2025).
  • Going back by year, Interest & Investment Income was $157.51 million in FY2024 (+46.7%), $107.39 million in FY2023 (+288.2%), $27.67 million in FY2022 (+661.5%) and $3.63 million in FY2021 (-43.8%).
  • The Q2 2026 figure represents the highest quarterly Interest & Investment Income in data going back to Q3 2016.
  • Year-over-year, Interest & Investment Income has increased for four consecutive quarters, with growth averaging 11.2% over the last eight quarters.
  • The fastest year-over-year change in Interest & Investment Income over five years came in Q3 2022 (growth of 894.7%), and the weakest in Q1 2025 (a decline of 4.9%).
  • Business Quant data shows ARGX's Interest & Investment Income at $44 million (Q1 2026), $44.87 million (Q4 2025) and $42.7 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Eli Lilly 1,122.91 Bn 1,091.50 Bn 19.71 Bn -
2 Johnson & Johnson 615.09 Bn 533.62 Bn 17.26 Bn 219.00 Mn
3 AbbVie 504.75 Bn 477.86 Bn 12.70 Bn -
4 Merck 360.18 Bn 314.55 Bn 12.21 Bn -
5 Novartis Ag 292.05 Bn 256.04 Bn 11.24 Bn -
6 Astrazeneca 256.09 Bn 229.78 Bn 12.86 Bn 80.00 Mn
7 Amgen 233.63 Bn 189.02 Bn 7.24 Bn -
8 Gilead Sciences 194.49 Bn 168.69 Bn 6.22 Bn -
9 Pfizer 168.35 Bn 114.99 Bn 10.94 Bn -
10 Argenx Se 50.23 Bn 34.19 Bn 1.37 Bn 48.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 48.00 Mn
Mar 31, 2026 44.00 Mn
Dec 31, 2025 44.87 Mn
Sep 30, 2025 42.70 Mn
Jun 30, 2025 38.40 Mn
Mar 31, 2025 37.00 Mn
Dec 31, 2024 39.10 Mn
Sep 30, 2024 40.59 Mn
Jun 30, 2024 38.93 Mn
Mar 31, 2024 38.90 Mn
Dec 31, 2023 40.31 Mn
Sep 30, 2023 30.05 Mn
Jun 30, 2023 20.44 Mn
Mar 31, 2023 16.59 Mn
Dec 31, 2022 13.93 Mn
Sep 30, 2022 8.01 Mn
Jun 30, 2022 4.91 Mn
Mar 31, 2022 821,000.00
Dec 31, 2021 1.20 Mn
Sep 30, 2021 805,000.00
API Access

Argenx Se Interest & Investment Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=ARGX&period=max&api_key=YOUR_API_KEY